Timothy J. Sangiovanni
CIK 1698328 · SVP, Finance & Corp Controller · last filed 2026-05-29
Timothy J. Sangiovanni is a SVP, Finance & Corp Controller who has filed 20 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ZVRA, was dated May 29, 2026. Across all open-market trades the lifetime net is −$49.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $308.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ZVRA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2500 CROSSPARK RD, STE E-126
CORALVILLE, IA 52241
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | SVP, Finance & Corp Controller | 29,590 | $10.41 | $308.0K | -$61.6K | 7 | 2026-05-29 |
| ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | SVP, Corporate Controller | 1,125 | $5.81 | $6.5K | $12.6K | 11 | 2023-01-11 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2026-02-04 | ZVRA | Sell (S) | −3,000 | -$27.5K | EDGAR |
| 2026-02-02 | ZVRA | Mixed | +16,249 | -$15.4K | EDGAR |
| 2026-01-30 | ZVRA | Notice (144) | −4,750 | -$42.1K | EDGAR |
| 2025-02-14 | ZVRA | Sell (S) | −3,000 | -$23.6K | EDGAR |
| 2025-02-13 | ZVRA | Notice (144) | −3,000 | -$23.2K | EDGAR |
| 2025-02-03 | ZVRA | Mixed | +11,666 | $0 | EDGAR |
| 2024-02-02 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2023-03-13 | ZVRA | Buy (P) | +1,200 | $5.0K | EDGAR |
| 2023-01-11 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.